ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,865,000 | +16.4% | 300,000 | +33.3% | 5.14% | +21.6% |
| Q2 2021 | $15,345,000 | +5.3% | 225,000 | +7.1% | 4.22% | +1.4% |
| Q1 2021 | $14,572,000 | -5.2% | 210,000 | +5.0% | 4.16% | -8.9% |
| Q4 2020 | $15,366,000 | +37.0% | 200,000 | +33.3% | 4.57% | +33.2% |
| Q3 2020 | $11,219,000 | +1.8% | 150,000 | -14.3% | 3.43% | +4.0% |
| Q2 2020 | $11,016,000 | +138.4% | 175,000 | +59.1% | 3.30% | +62.1% |
| Q1 2020 | $4,620,000 | +45.3% | 110,000 | +57.1% | 2.04% | +64.4% |
| Q4 2019 | $3,179,000 | – | 70,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |